A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	WO2001068679A9 Peptides targeting specifically tumor-derived endothelial cells
12/19/2002	US20020194643 Method for producing hemin proteins using plant cells, resulting proteins and products containing same
12/19/2002	US20020194637 Generation of genetic engineered embryonic stem cells for use in the treatment of parkinson's, huntington's, alzheimer's, diabetes, multiple sclerosis, muscular, bone and liver disorders
12/19/2002	US20020194636 Transgenic mice containing polycystin-related gene disruptions
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194630 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
12/19/2002	US20020193875 Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin
12/19/2002	US20020193730 Intrapulmonary delivery of polypeptide growth factors and cytokines
12/19/2002	US20020193584 Endogenous and non-endogenous versions of human G protein-coupled receptors
12/19/2002	US20020193582 69624, a novel human transporter family member and uses therefor
12/19/2002	US20020193580 Synthetic nucleotide sequences for use as tools in controlling genetic engineering
12/19/2002	US20020193575 Fusion protein for use in the treatment of allergies
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193570 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/19/2002	US20020193569 Immunoconjugate for use in the treatment of cancer
12/19/2002	US20020193567 Secreted proteins and polynucleotides encoding them
12/19/2002	US20020193562 Angiotensin converting enzyme (ACE); neutral endopeptidase (NEP); containing a dipeptide derived from an amino acid, or a conformationally restricted dipeptide mimic
12/19/2002	US20020193561 P53 protein variants and therapeutic uses thereof
12/19/2002	US20020193560 Cyclic polypeptide compound for use as microbiocide
12/19/2002	US20020193442 Method and compositions for the treatment or amelioration of female sexual dysfunction
12/19/2002	US20020193416 Synergistic tumorcidal response induced by histamine
12/19/2002	US20020193338 Applying a biocompatible matrix containing the DNA molecule to a wound in the body, so that repair cells that migrate to the wound site infiltrate the matrix, acquire the DNA molecule, and express the gene product encoded by the DNA in vivo
12/19/2002	US20020193337 Gene therapy by secretory gland expression
12/19/2002	US20020193331 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
12/19/2002	US20020193326 Methods of inhibiting proliferative diseases
12/19/2002	US20020193325 Inhibiting growth of a tumor cell by introducing to the cell an effective amount of p19ARF protein or mimetic thereof, and p53
12/19/2002	US20020193323 Compositions and methods for promoting a healthy cardiovascular system and enhancing blood flow
12/19/2002	US20020193312 For therapy of asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis, meningitis, encephalitis, stroke, nephritis
12/19/2002	US20020193311 Novel cytostatic conjugates with integrin ligands
12/19/2002	US20020193310 For therapy of hyperglycemic disorders
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193308 Recombinant protein and its use in therapy and diagnostics
12/19/2002	US20020193307 Antagonism of endothelin actions
12/19/2002	US20020193306 Treatment of allergic rhinitis
12/19/2002	US20020193305 Cytokine receptor common gamma chain like
12/19/2002	US20020193304 Anti-HIV agents
12/19/2002	US20020193303 58860, a human cholesteryl ester hydrolase and uses therefor
12/19/2002	US20020193302 Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/19/2002	US20020193301 Administering transforming growth factor alpha (TGF- alpha ) polypeptide, fragments and mimetics fragments and mimetics for protection of a tissue or an organ from damage by a cytotoxic agent
12/19/2002	US20020193300 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020193299 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/19/2002	US20020193298 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
12/19/2002	US20020193297 Recombinant human alpha-fetoprotein as an immunosuppressive agent
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020193294 For inhibiting functions such as cell adhesion and the formation of tissue permeability barriers
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020193291 Treating NIDDM with RXR agonists
12/19/2002	US20020193290 Methods for fine powder formation
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020193286 Inhibiting the growth of neoplastic lesions by administering to the patient a GnRH analog and cyclic Guanosine Monophosphate (c-GMP) phosphodiesterase inhibitor
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192821 Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease
12/19/2002	US20020192817 Generation of tyrosine hydroxylase; obtain nervous system stem cell, incubate with fibroblast growth factor, kinase and dopamine, recover differentiated cells
12/19/2002	US20020192801 Human uridine diphosphate galactose-4-epimerase
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192798 Zcys9: a member of the cystatin superfamily
12/19/2002	US20020192794 Purification of plasmin; obtain sample of plasminogen, incubate with activator, recover plasmin
12/19/2002	US20020192790 Polynucleotides for use in the treatment and diagnosis of cancer and autoimmune diseases
12/19/2002	US20020192787 Polypeptide for use in the diagnosis, treatment, and prevention of cancer and developmental defects
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192780 Novel anti-inflammatory peptides
12/19/2002	US20020192779 Nucleotide sequences coding polypeptide for use in the treatment of cancer
12/19/2002	US20020192763 Compositions and methods for the therapy and diagnosis of prostate cancer
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192754 Generation of preferential serine proteases; obtain genetically engineered prokaryotic cell, transform with gene expressing serine proteases, recover serine proteases
12/19/2002	US20020192751 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of sepsis and inflammatory defects
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192748 Novel polynucleotides and polypeptides encoded thereby
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192734 Used as an additive in a tube to neutralize residual heparin in specimens taken from heparinized patients and accelerate clotting; irradiation stable; for minimizing interference from heparin in a blood sample
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192724 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
12/19/2002	US20020192721 Modular molecular clasps and uses thereof
12/19/2002	US20020192714 Separation of polypeptides in sample; obtain sample, incubate with matrix, extract and recover polypeptides
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192704 Protein for use in the treatment of diabebtes, gastrointestinal disorders and kidney defects
12/19/2002	US20020192700 Classification of cells; obtain cells, incubate with preferential nucleotide sequences, detect hybridzation, classify cells
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192685 Method for target site selection and discovery
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192666 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192633 Non-lethal method for extracting crude hemocyanin from gastropod molluscs
12/19/2002	US20020192354 Calorically dense liquid oral supplement
12/19/2002	US20020192302 Transdermal and topical administration of antidepressant drugs using basic enhancers
12/19/2002	US20020192301 Transdermal and topical administration of antihypertensive agents using basic enhancers
12/19/2002	US20020192300 Transdermal and topical administration of antipsychotic agents using basic enhancers
12/19/2002	US20020192276 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
12/19/2002	US20020192271 Method for causing local hemostasis and hemostatic composition for local hemostasis
12/19/2002	US20020192263 Allograft bone composition having a gelatin binder
12/19/2002	US20020192243 Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
12/19/2002	US20020192242 Bone disorders; drug delivery; mixture of bone density regulator and base
12/19/2002	US20020192240 Therapy for injured muscles

1 ... 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 ... 3163